Institutional Ownership Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA). We have compiled data on the 340 institutions that hold shares in the stock, with a total of 247 Million shares, which have been reported (via 13F filing form) to have a value of $1.39 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
741,418
shares
|
$4.29 Million
0.0% of portfolio
|
Q4 2024
Reduced 69.75%
|
|
Qvt Financial LP
New York, NY |
Feb 14, 2025 Q4 2024 |
678,564
shares
|
$3.92 Million
0.49% of portfolio
|
Q2 2021
Added 15.11%
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
617,803
shares
|
$3.57 Million
0.0% of portfolio
|
Q4 2024
Added 2.19%
|
|
Wells Fargo & Company
San Francisco, CA |
Feb 12, 2025 Q4 2024 |
580,245
shares
|
$3.35 Million
0.0% of portfolio
|
Q4 2024
Added 0.76%
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
577,265
shares
|
$3.34 Million
0.01% of portfolio
|
Q4 2024
Added 673.9%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
563,577
shares
|
$3.26 Million
0.03% of portfolio
|
Q4 2024
Added 0.2%
|
|
Rafferty Asset Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
554,141
shares
|
$3.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 15.13%
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
500,000
shares
|
$2.89 Million
0.28% of portfolio
|
Q1 2024
Reduced 50.0%
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
484,042
shares
|
$2.8 Million
0.0% of portfolio
|
Q4 2024
Added 131.86%
|
|
Sei Investments CO
Oaks, PA |
Feb 11, 2025 Q4 2024 |
478,481
shares
|
$2.77 Million
0.0% of portfolio
|
Q4 2024
Added 1.91%
|
|
Neo Ivy Capital Management
New York, NY |
Feb 18, 2025 Q4 2024 |
453,138
shares
|
$2.62 Million
0.68% of portfolio
|
Q4 2024
New holding
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
445,000
shares
|
$2.57 Million
0.69% of portfolio
|
Q3 2023
Added 584.62%
|
|
Rothschild & CO Asset Management Us Inc.
New York, NY |
Feb 14, 2023 Q4 2022 |
418,929
shares
|
$2.42 Million
0.04% of portfolio
|
Q4 2022
Reduced 7.09%
|
|
Swiss National Bank
Zurich, V8 |
Feb 10, 2025 Q4 2024 |
417,856
shares
|
$2.42 Million
0.0% of portfolio
|
Q4 2024
Added 9.28%
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
416,237
shares
|
$2.41 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
385,770
shares
|
$2.23 Million
0.0% of portfolio
|
Q4 2024
Added 8.95%
|
|
Banque Pictet & Cie Sa
|
Jan 30, 2025 Q4 2024 |
376,591
shares
|
$2.18 Million
0.02% of portfolio
|
Q4 2024
Added 17.04%
|
|
Hennion & Walsh Asset Management, Inc.
|
Jan 14, 2025 Q4 2024 |
335,981
shares
|
$1.94 Million
0.12% of portfolio
|
Q4 2024
Reduced 4.4%
|
|
Cinctive Capital Management LP
New York, NY |
Feb 12, 2025 Q4 2024 |
329,204
shares
|
$1.9 Million
0.13% of portfolio
|
Q4 2024
New holding
|
|
First Trust Advisors LP
Wheaton, IL |
Feb 13, 2025 Q4 2024 |
324,246
shares
|
$1.87 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Td Asset Management Inc
|
Feb 11, 2025 Q4 2024 |
311,078
shares
|
$1.8 Million
0.0% of portfolio
|
Q4 2024
Reduced 15.76%
|
|
Cm Management, LLC
|
Feb 07, 2025 Q4 2024 |
300,000
shares
|
$1.73 Million
2.08% of portfolio
|
Q4 2024
Added 20.0%
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
295,228
shares
|
$1.71 Million
0.0% of portfolio
|
Q4 2024
Added 152.4%
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
279,627
shares
|
$1.62 Million
0.0% of portfolio
|
Q4 2024
Reduced 10.35%
|
|
Parametrica Management LTD
|
Feb 11, 2025 Q4 2024 |
261,090
shares
|
$1.51 Million
2.57% of portfolio
|
Q2 2024
Added 98.41%
|